Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of...
21 insider purchases on record · latest filing 2025-08-12.
Insiders have also filed 47 sale transactions at HRTX.